Comprehensive Oral Intervention in Patients With AMI
Primary Purpose
Acute Myocardial Infarction, Dental Diseases
Status
Unknown status
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
active dental procedure
post-myocardial infarction management
basic periodontal examinations
Sponsored by
About this trial
This is an interventional prevention trial for Acute Myocardial Infarction
Eligibility Criteria
Inclusion Criteria:
- Adults over 18
- Patients diagnosed with type 1 or 2 MI according to the Fourth Universal Definition of Myocardial Infarction (2018) criteria
- Patients with baseline hsCRP (high-sensitivity C-reactive protein) elevated above 1.0 mg / dL
Exclusion Criteria:
clinical exclusion criteria
- Inability to provide informed consent
- Patients who are predicted to have low compliance
- Those whose life expectancy is less than 3 months due to cardiovascular disease or other reasons
- Those who are considered to be too poor condition to perform dental treatment or have a high risk of bleeding
- Those who need active dental treatment such as extraction
- Patients suspected of having active infection
- Those who are taking long-term systemic antibiotics or receiving immunosuppressive treatment
periodontal exclusion criteria
- Fully edentulous (Except for fixed implant restorations)
- If more than 15 teeth and implants do not exist
- If the last dental visit experience is less than 6 months
- If periodontal treatment is not possible by the researcher
Sites / Locations
- Seoul National University Bundang HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
treatment group
control group
Arm Description
post-myocardial infarction management basic periodontal examinations active dental procedure
post-myocardial infarction management basic periodontal examinations
Outcomes
Primary Outcome Measures
hsCRP
hsCRP(high sensitivity C-reactive protein), mg/dL
Secondary Outcome Measures
surrogate blood markers
FBS & Total cholesterol & LDL-cholesterol & HDL-cholesterol & Triglyceride & Apolipoprotein A & Apolipoprotein B, mg/dL
patient symptom
NYHA functional class
Systolic & diastolic blood pressure
automated blood pressure, mmHg
Exercise performance
Treadmill test
Death
number of cardiovascular death
unscheduled coronary revascularization
number of unscheduled coronary revascularization
stroke
number of stroke
HF admission
number of HF admission
unstable angina
number of unstable angina
recurrent MI
number of recent MI
Full Information
NCT ID
NCT04012541
First Posted
June 14, 2019
Last Updated
July 8, 2019
Sponsor
Seoul National University Bundang Hospital
Collaborators
National Research Foundation of Korea
1. Study Identification
Unique Protocol Identification Number
NCT04012541
Brief Title
Comprehensive Oral Intervention in Patients With AMI
Official Title
A Randomized Control Trial of Comprehensive Oral Intervention in Patients With Acute Myocardial Infarction: a Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
July 2019
Overall Recruitment Status
Unknown status
Study Start Date
July 5, 2019 (Actual)
Primary Completion Date
March 31, 2021 (Anticipated)
Study Completion Date
March 31, 2021 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Seoul National University Bundang Hospital
Collaborators
National Research Foundation of Korea
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
5. Study Description
Brief Summary
The investigators performed a randomized controlled trial with investigator-masked design enrolling subjects with acute myocardial infarction.
The purpose of this study is to find a treatment strategy to reduce the risk of recurrence of myocardial infarction through oral hygiene improvement.
Detailed Description
Subjects were divided into a treatment group and a control group. Both sides receive basic periodontal examinations, but the treatment group receives active dental procedure such as scaling and root planing. Both groups also receive post-myocardial infarction management.
As part of a pilot study, this study used the primary outcome measure for changes in surrogate markers rather than clinical outcomes.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Acute Myocardial Infarction, Dental Diseases
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
This study is randomized controlled trial. Patients who agreed to the study were randomly assigned to the intervention group and control group at a 1: 1 ratio.
Masking
Investigator
Masking Description
Participating patients and dentists are not able to blind information about random allocation. However, in order to reduce the bias, the cardiologist who treats the patient and prescribes the medicines performs an investigator-masked design that masks information about the treatment group.
Allocation
Randomized
Enrollment
68 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
treatment group
Arm Type
Experimental
Arm Description
post-myocardial infarction management
basic periodontal examinations
active dental procedure
Arm Title
control group
Arm Type
Active Comparator
Arm Description
post-myocardial infarction management
basic periodontal examinations
Intervention Type
Procedure
Intervention Name(s)
active dental procedure
Intervention Description
scaling and root planing
Intervention Type
Drug
Intervention Name(s)
post-myocardial infarction management
Other Intervention Name(s)
dual antiplatelet drug
Intervention Description
aspirin, clopidogrel, ticagrelor
Intervention Type
Radiation
Intervention Name(s)
basic periodontal examinations
Intervention Description
panorama radiograph : full mouth periapical radiograph
Primary Outcome Measure Information:
Title
hsCRP
Description
hsCRP(high sensitivity C-reactive protein), mg/dL
Time Frame
at 3 months
Secondary Outcome Measure Information:
Title
surrogate blood markers
Description
FBS & Total cholesterol & LDL-cholesterol & HDL-cholesterol & Triglyceride & Apolipoprotein A & Apolipoprotein B, mg/dL
Time Frame
at 3 months
Title
patient symptom
Description
NYHA functional class
Time Frame
at 3 months & 12 months
Title
Systolic & diastolic blood pressure
Description
automated blood pressure, mmHg
Time Frame
at 3 months & 12 months
Title
Exercise performance
Description
Treadmill test
Time Frame
at 3 months
Title
Death
Description
number of cardiovascular death
Time Frame
at 12 months
Title
unscheduled coronary revascularization
Description
number of unscheduled coronary revascularization
Time Frame
at 12 months
Title
stroke
Description
number of stroke
Time Frame
at 12 months
Title
HF admission
Description
number of HF admission
Time Frame
at 12 months
Title
unstable angina
Description
number of unstable angina
Time Frame
at 12 months
Title
recurrent MI
Description
number of recent MI
Time Frame
at 12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Adults over 18
Patients diagnosed with type 1 or 2 MI according to the Fourth Universal Definition of Myocardial Infarction (2018) criteria
Patients with baseline hsCRP (high-sensitivity C-reactive protein) elevated above 1.0 mg / dL
Exclusion Criteria:
clinical exclusion criteria
Inability to provide informed consent
Patients who are predicted to have low compliance
Those whose life expectancy is less than 3 months due to cardiovascular disease or other reasons
Those who are considered to be too poor condition to perform dental treatment or have a high risk of bleeding
Those who need active dental treatment such as extraction
Patients suspected of having active infection
Those who are taking long-term systemic antibiotics or receiving immunosuppressive treatment
periodontal exclusion criteria
Fully edentulous (Except for fixed implant restorations)
If more than 15 teeth and implants do not exist
If the last dental visit experience is less than 6 months
If periodontal treatment is not possible by the researcher
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Si-Hyuck Kang, MD
Phone
82317877027
Email
eandp303@gmail.com
First Name & Middle Initial & Last Name or Official Title & Degree
Ji Yeon Yoon
Phone
82317873974
Email
r1999@snubh.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Si-Hyuck Kang, MD
Organizational Affiliation
Seoul National University Bundang Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Seoul National University Bundang Hospital
City
Seongnam
State/Province
Gyeonggi-do
ZIP/Postal Code
13620
Country
Korea, Republic of
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Si-Hyuck Kang, MD
Phone
82317877027
Email
eandp303@gmail.com
First Name & Middle Initial & Last Name & Degree
Ji Yeon Yoon
Phone
82317873974
Email
r1999@snubh.org
12. IPD Sharing Statement
Plan to Share IPD
No
Citations:
PubMed Identifier
36194420
Citation
Ye Z, Cao Y, Miao C, Liu W, Dong L, Lv Z, Iheozor-Ejiofor Z, Li C. Periodontal therapy for primary or secondary prevention of cardiovascular disease in people with periodontitis. Cochrane Database Syst Rev. 2022 Oct 4;10(10):CD009197. doi: 10.1002/14651858.CD009197.pub5.
Results Reference
derived
Learn more about this trial
Comprehensive Oral Intervention in Patients With AMI
We'll reach out to this number within 24 hrs